July 15, 2025Nanomedicine

Regulating nanomedicines: challenges, opportunities, and the path forward

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This review discusses regulatory gaps in nanomedicine, highlighting challenges in safety and efficacy assessments for stakeholders.

Nanomedicines face significant challenges in regulatory frameworks impacting their clinical translation.
Issues such as biocompatibility and nanotoxicology hinder the safe application of these therapies.
A lack of consensus among global regulatory systems complicates the development of new nanomedicine treatments.
Establishing a coherent regulatory framework is essential for fostering innovation in nanomedicine.

Mangla et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark